Regulon

Regulon: R-510

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
142.7621314Pr-3Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1356 ENSG00000047457 CP D6RE86
25771 ENSG00000054611 TBC1D22A Q8WUA7
857 ENSG00000105974 CAV1 A0A024R757
59 ENSG00000107796 ACTA2 P62736
1362 ENSG00000108582 CPD O75976
800 ENSG00000122786 CALD1 Q05682
3142 ENSG00000136630 HLX Q14774
2590 ENSG00000143641 GALNT2 Q10471
1836 ENSG00000155850 SLC26A2 P50443
5734 ENSG00000171522 PTGER4 P35408
284119 ENSG00000177469 PTRF Q6NZI2
23765 ENSG00000177663 IL17RA Q96F46
64764 ENSG00000182158 CREB3L2 Q70SY1
5770 ENSG00000196396 PTPN1 P18031

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DINOPROSTONEPTGER1Small moleculeAGONISTProstaglandin E2 receptor agonist40
BRODALUMABIL17RAAntibodyANTAGONISTInterleukin-17 receptor A antagonist40
CR-6086PTGER4Small moleculeANTAGONISTProstanoid EP4 receptor antagonist20
GRAPIPRANTPTGER4Small moleculeANTAGONISTProstanoid EP4 receptor antagonist20
RIVENPROSTPTGER4Small moleculeAGONISTProstanoid EP4 receptor agonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-510

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-02200OR4N2down-regulatesNFYAactivatesR-510112Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

DINOPROSTONE, BRODALUMAB, CR-6086, GRAPIPRANT, RIVENPROST

CMF-08615FOXR2down-regulatesNFYAactivatesR-510111Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

DINOPROSTONE, BRODALUMAB, CR-6086, GRAPIPRANT, RIVENPROST

CMF-20079ARHGEF16down-regulatesNFYAactivatesR-510111Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

DINOPROSTONE, BRODALUMAB, CR-6086, GRAPIPRANT, RIVENPROST

CMF-28458MYO9Bdown-regulatesNFYAactivatesR-510111Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

DINOPROSTONE, BRODALUMAB, CR-6086, GRAPIPRANT, RIVENPROST